Annual report [Section 13 and 15(d), not S-K Item 405]

Schedule I - Condensed Balance Sheets (Details)

v3.25.0.1
Schedule I - Condensed Balance Sheets (Details) - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Current assets:        
Cash and cash equivalents $ 261,758 $ 218,120 $ 298,529 $ 252,141
Other current assets 97,413 118,472    
Total current assets 722,208 749,113    
Non-current assets:        
Deferred tax asset 67,689 52,293    
Total assets 3,620,658 3,650,364    
Current liabilities:        
Long-term debt, current portion 12,944 16,792    
Other current liabilities 159,239 179,536    
Total current liabilities 445,490 486,224    
Non-current liabilities:        
Long-term debt, net 868,055 828,647    
Other non-current liabilities 223,528 266,602    
Total liabilities 3,243,792 3,274,247    
Series A redeemable preferred stock 100,000 100,000    
Shareholders' equity 276,866 276,101    
Total liabilities, redeemable preferred stock and equity 3,620,658 3,650,364    
Parent Company        
Current assets:        
Cash and cash equivalents 25,137 27,220    
Other current assets 13,885 11,983    
Total current assets 39,022 39,203    
Non-current assets:        
Investment in subsidiaries 373,753 356,048    
Loans to subsidiaries 450,000 450,000    
Deferred tax asset 2,384 1,941    
Total assets 865,159 847,192    
Current liabilities:        
Long-term debt, current portion 587 671    
Other current liabilities 11,363 5,896    
Total current liabilities 11,950 6,567    
Non-current liabilities:        
Long-term debt, net 445,263 444,432    
Loans from investees 30,000 0    
Other non-current liabilities 1,080 20,092    
Total liabilities 488,293 471,091    
Series A redeemable preferred stock 100,000 100,000    
Shareholders' equity 276,866 276,101    
Total liabilities, redeemable preferred stock and equity $ 865,159 $ 847,192